You are here: Home / Pharmacology / Research / Overview / Publications archive

Publications: 2003

On this page:

Book chapters

  1. Vandenberg RJ and Ryan RM (2003) Allosteric modulation of glutamate transporters. Molecular Neuropharmacology: Strategies and Methods, 161-174.
Back to top

Refereed journal articles

  1. Black JL, Burgess JK and Johnson PRA (2003) Airway smooth muscle - its relationship to the extracellular matrix.Respiratory Physiology & Neurobiology, 137, 339-346
  2. Borgland SL, Connor M, *Osborne PB, *Furness JB, and Christie MJ (2003) Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization and endocytosis of mu-opioid receptors. J. Biol. Chem, 10.1074/jbc.M300525200
  3. Burgess JK, Johnson PRA, Qi Ge, Au WW, Poniris MH, McParland BE, King G, Roth M and Black JL (2003). Expression of connective tissue growth factor in asthmatic airway smooth muscle cells, American Journal of Respiratory and Critical Care Medicine, 67, 71-77
  4. Carlin SM, Roth M, Black JL. Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells (2003) Am J Physiol Lung Cell Mol Physiol. 284(6):L1020-6. Epub 2003 Feb 07
  5. Chambers LS, Black JL, Ge Q, Carlin SM, Au WW, Poniris M, Thompson J, Johnson PR, Burgess JK.PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle celsl (2003).Am J Physiol Lung Cell Mol Physiol. 5(3):L619-27
  6. **Chebib M, Duke RK, Connor M, Mewett KN and Johnston GAR (2003) Convulsant actions of calycanthine, Toxicology and Applied Pharmacology, 190. 58-64
  7. Coverdale SA, Samarasinghe DA, Lin R, Kench J, Byth K, Khan MH, Crewe E, Liddle C, George J, Farrell GC (2003) Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression. Am J Gastroenterol. Jun;98(6):1384-90
  8. Double KL, Halliday GM, Henderson J, Griffiths FM, Heinemann T, Riederer P, Gerlach M (2003) The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration. Exp Neurol. 184(1):530-5
  9. Hack SP, Vaughan CW, Christie MJ. (2003) Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology. Oct;45(5):575-84
  10. **Hanrahan JR, **Chebib M, **Davucheron NM, Hall BJ and Johnston GAR (2003) Semisynthetic preparation of amentoflavone: a negative modulator at GABA-A receptors Bioorganic & Medicinal Chemistry Letters, 13/14, 2281-2284
  11. Henderson JM, *Lu Y, *Wang S, *Cartwright H, *Halliday GM (2003) Olfactory deficits and sleep disturbances in Parkinson's disease: a case-control survey.Journal of Neurology, Neurosurgery and Psychiatry,, 74, 1-3
  12. Henderson JM, Watson S, Halliday GM, Heinemann T, Gerlach G (2003) Relationsships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat.Behavioural Brain Research (in press)
  13. Henderson JM and Watson S (2003) Convulsive and postural effects of lesioning the mid-substantia nigra pars reticulata in naive and 6-OHA lesioned rats.Brain Research Bulletin (in press)
  14. Hoskins JM, Shenfield GM, Gross AS (2003) Concordance between proguanil phenotype and CYP2C19 genotype in Chinese. Eur J Clin Pharmacol. Nov;59(8-9):611-4. Epub 2003 Sep 12
  15. Huang SH, Duke RK, **Chebib M, *Sasaki K, *Wada K and Johnston GAR (2003) 'Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant a1b2g2L GABA-A receptors' European Journal of Pharmacology, 464, 1-8
  16. Jennings EA, Vaughan CW, Roberts LA, Christie MJ. (2003) The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. J Physiol. 2003 Apr 1;548(Pt 1):121-9. Epub 2003 Jan 31
  17. Johnston GAR (2003) Dietary chemicals and brain function. Journal & Proceedings of the Royal Society of New South Wales, 135, 57-71
  18. Johnston GAR, Chebib M, Hanrahan JR and Mewett KN (2003) GABA-C receptors as drug targets, Current Drug Targets - CNS & Neurological Disorders, 2, 260-268
  19. Katsifis A, Mardon K, Mattner F, Loc'h C, McPhee ME, Dikic B, Kassiou M, Ridley DD. (2003) Pharmacological evaluation of [123I]iodobretazenil: A radioligand for in vivo studies of central benzodiazepine receptors. Nucllear Medicine and Bioilogy, 30, 191-198
  20. *Krehan D, *Frølund B, *Krogsgaard-Larsen, P, *Kehler J, Johnston GAR and **Chebib M (2003) 'Phosphinic, phosphonic and seleninic acid bioisosteres of isonipecotic acid as novel and selective GABA-C receptor antagonists' Neurochemistry International, 42, 561-565
  21. *Krehan D, *Frølund B, *Krogsgaard-Larsen, P, Johnston GAR and Chebib M (2003) 'Aza-THIP and related analogues of THIP as GABA-C antagonists', Bioorganic and Medicinal Chemistry, 11, 4891-4896
  22. Kumar D, Wallington-Beddoe C, George J, Lin R, Samarasinghe D, Liddle C, Farrell GC (2003) Effectiveness of interferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting. Medical Journal of Australia, 178, 267-271
  23. *Lai MK, *Tsang SW, *Francis PT, *Esiri MM, *Hope T, *Lai OF, Spence I and *Chen CP (2003) [3H] GR113808 binding to serotonin 5-HT4 receptors in the postmortem neocortex of Alzheimer disease: a clinicopathological study. Journal of Neural Transmission 110, 779-788
  24. Liddle C and Robertson GR (2003) Predicting inductive drug-drug interactions. Pharmacogenomics4(2), 141-152
  25. Li, KM; Clarke, SJ, Rivory, LP (2003) Quantitation of plasma thymidine by High-Performance Liquid Chromatography / Atmospheric Pressure Chemical Ionization Mass Spectrometry and its application to pharmacodynamic studies in cancer patients. Analytica Chimica Acta (in press)
  26. Lonergan T, Goodchild AK, Christie MJ, Pilowsky PM. (2003) Mu opioid receptors in rat ventral medulla: effects of endomorphin-1 on phrenic nerve activity. Respir Physiol Neurobiol. 138(2-3):165-78
  27. Lonergan T, Goodchild AK, Christie MJ, Pilowsky PM (2003) Presynaptic delta opioid receptors differentially modulate rhythm and pattern generation in the ventral respiratory group of the rat. Neuroscience. 121(4):959-73
  28. McClean MA, Matheson MJ, McKay K, Johnson PR, Rynell AC, Ammit AJ, Black JL, Berend N (2003) Low lung volume alters contractile properties of airway smooth muscle in sheep. Eur Respir J; 22(1):50-6
  29. **McGregor, IS; **Gurtman, CG; **Clemens, KJ; **Morley, K C; Li, KM; **Blokland, A; **Cornish, JL; **Hunt, GE (2003) Increased anxiety and "depressive" symptoms months after MDMA ("Ecstasy") in rats : drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology , 28, 1472-1484
  30. **McGregor, IS; **Gurtman, CG; **Morley, KC; **Clemens, KJ; **Blokland, A; Li, KM; **Cornish, JL; **Hunt, GE (2003) Increased Anxiety, Altered 5-HT Receptor and Transporter Density, but no 5-HT Depletion, Three Months after Brief Low-Dose MDMA ("Ecstasy") In Rats. Neuropsychopharmacology (in press)
  31. Mesotten D, Van den Berghe G, Liddle C, Coulter S, McDougall F, Baxter RC and Delhanty PJD. (2003) Growth hormone modulation of the rat hepatic bile transporter system in endotoxin-induced cholestasis. Endocrinology, 144(9):4008-17
  32. Mitchell VA, Christie MJ, Vaughan CW (2003) Developmental changes in the alpha-adrenergic responses of rat periaqueductal grey neurons.Neuroreport, 26;14(12):1637-9
  33. Mitrovic AD and Vandenberg RJ (2003) Glutamate Transporters: Redefining the View of a Transporter, Australian Biochemist, 34, P 8-1
  34. Pearlman R-J, Aubrey KR and Vandenberg RJ (2003) Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. Journal of Neurochemistry (in press)
  35. Qu X, Dang L, Seale JP (2003) Inhibitory effect of Hypocrella bambuase on protein kinase C in liver and skeletal muscle of obese Zucker rats. Amer J Chinese Med (in press)
  36. Quinlivan M, Mattner F, Papazian V, Zhou J, Katsifis A, Emond P, Chalon S, Kozikowski A, Guilloteau D and Kassiou M (2003) Synthesis and evaluation of iodine-123 labelled tricyclic tropanes as radioligands for the serotonin transporter. Nuclear Medicine and Biology, 30, 741-746
  37. Robertson GR, Field J, Goodwin B, Bierach S, Tran M, Lehnert A, Liddle C. (2003) Transgenic mouse models of human CYP3A4 gene regulation. Mol Pharmacol., 64(1):42-50
  38. Roger G, Lagnel B, Besret L, Bramoull- Y, coulon C, Ottaviani M, Kassiou M, Bottlaender M, Valette H, Doll- F (2003) Synthesis, Radiosynthesis and In Vivo Evaluation of 5-[3-(4-Benzylpiperidin-1-yl) prop-1-ynyl]-1,3-dihydrobenzoimidazol-2-[11C] one, asa a potent NR1A/2B Subtype Selective NMDA PET Radiotracer, Bioorganic & Medicinal Chemistry, 11, 5401-5408
  39. Roth, M., P.R.A. Johnson, P. Borger, G.G. King, Q. Ge, J. Burgess, J. Black, and M. Tamm, (2003) Lack of the transcription factor CEBP-alpha and different intracellular signalling in asthmatic bronchial smooth muscle cells. European Respiratory Journal, 22: 42S-42S
  40. Salviero KA, Clarke SJ and Rivory L (2003)Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. The Lancet Oncology, 4, 224-23
  41. Slaviero KA, Read JA, Clarke SJ, Rivory LP (2003) Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer. 46(2):148-57
  42. Slaviero KA, Clarke SJ, McLachlan AJ, Blair EY, Rivory LP. (2003) Population pharmacokinetics of weekly docetaxel in patients with advanced cancer. Br J Clin Pharmacol. 57(1):44-53
  43. Seale JP (2003) Science and physicianly practice - are they compatible? Clin Exp Pharmac Physiol, (in press)
  44. Stedman CA, Robertson GR, Coulter SA, Liddle C. (2003) Feed-forward regulation of bile acid detoxification by CYP3A4: Studies in humanized transgenic mice, J Biol Chem. Dec 17, p.p 1-34
  45. Tan WC, Seale JP, Chaoenrantanakul S, Hardiarto M, Ip M, Mahayiddin A, Zhong NS, Schau B (2003) COPD Prevalence in 12 Asian Countries: projections based on the COPD prevalence model, Respirology, 8.,192-198
  46. Tobin PJ, Dodds HM, Clarke S, Schnitzler M, Rivory LP. (2003) The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours. Oncol Rep. 10(6):1977-9
  47. Tsang SWY, Lai MKP, Francis PT, Wong PT-H, Spence I, Esiri MM, Keene J, Hope T and Chen CPL-H(2003) Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients, Neuro Report, 14, 1297-1300
  48. Turner JV, Cutler DJ, Spence I, Maddalena DJ (2003) Selective descriptor pruning for QSAR/QSPR studies using artificial neural networks. J Computational Chemistry, 24, 891-897
  49. Vaughan CW, Bagley EE, Drew GM, Schuller A, Pintar JE, Hack SP, Christie MJ (2003) Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br J Pharmacol. 139(2):362-7
Back to top

Other publications

  1. Temple DM and Johnston GAR 'Quality control of medicines, lessons from the Pan Pharmaceuticals recall' The ANZAAS Mercury, 2003, 18, 5
Back to top

NOTE:
**Member of another department, University of Sydney
*Not a member of the University of Sydney